IMRX
Immuneering Corp
4.30$
-0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.33 | -1.08 | -1.17 | -1.67 | -1.72 | -1.83 | -1.03 | |
| 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| 0.04 | 0.08 | 0.07 | 0.15 | 0.20 | 0.22 | 0.14 | |
| 0.21 | 0.08 | 0.06 | 0.15 | – | – | – | |
| 0.03 | 0.09 | 0.03 | 0.07 | -0.03 | -0.03 | 0.09 | |
| 0.00 | 0.00 | 0.00 | 0.03 | 0.01 | 0.00 | 0.00 | |
| 0.00 | 0.00 | -2.87 | 1.59 | 0.26 | 0.88 | -2.02 | |
| – | – | 5.48 | 0.00 | – | – | – | |
| 0.28 | – | – | – | – | – | – | |
| 1.27 | 2.81 | 5.48 | 0.00 | 1.00 | 0.18 | 5.15 | |
| 0.94 | 1.73 | 1.44 | -0.09 | -0.47 | -0.78 | 2.10 | |
| -0.33 | -1.09 | -1.17 | -1.70 | -1.74 | -1.84 | -1.03 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.